These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4511103)
1. Medroxyprogesterone acetate (Provera R ) therapy in acromegaly associated with heart disease. Wallach HW; Shapiro JR; Mendelson SH Med Ann Dist Columbia; 1973 Jan; 42(1):17-22. PubMed ID: 4511103 [No Abstract] [Full Text] [Related]
2. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly]. Liuzzi A; Chiodini PG; Botalla L; Silvestrini F Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003 [No Abstract] [Full Text] [Related]
3. A trial of medroxyprogesterone acetate in acromegaly. Rake JS; Hafiz SA; Lessof MH; Snodgrass GJ Clin Endocrinol (Oxf); 1972 Apr; 1(2):181-7. PubMed ID: 4664381 [No Abstract] [Full Text] [Related]
4. Influence of medroxyprogesterone acetate therapy on carbohydrate metabolism in acromegaly. Blum I; Karp M; Laron Z Isr J Med Sci; 1972 Jun; 8(6):881-2. PubMed ID: 5051830 [No Abstract] [Full Text] [Related]
8. Progestins in the medical management of active acromegaly. Lawrence AM; Kirsteins L J Clin Endocrinol Metab; 1970 May; 30(5):646-52. PubMed ID: 5462817 [No Abstract] [Full Text] [Related]
9. Acromegaly treated with chlorpromazine. A case study. Kolodny HD; Sherman L; Singh A; Kim S; Benjamin F N Engl J Med; 1971 Apr; 284(15):819-22. PubMed ID: 5549804 [No Abstract] [Full Text] [Related]
10. Spontaneous burned-out acromegaly with preservation of normal human growth hormone responses: diagnostic, historical, theoretical, and treatment aspects. Ewer RW; Kotheimer TG Johns Hopkins Med J; 1970 Oct; 127(4):199-212. PubMed ID: 4320105 [No Abstract] [Full Text] [Related]
11. [Treatment of acromegaly using CB-154 and medroxy-progesterone acetate]. Ichikawa Y; Yoshida K; Kawagoe M Horumon To Rinsho; 1977 Dec; 25(12):1303-4. PubMed ID: 598028 [No Abstract] [Full Text] [Related]
12. Acromegaly and cardiovascular disorders. A prospective study. McGuffin WL; Sherman BM; Roth F; Gorden P; Kahn CR; Roberts WC; Frommer PL Ann Intern Med; 1974 Jul; 81(1):11-8. PubMed ID: 4276173 [No Abstract] [Full Text] [Related]
13. [Experience with the treatment of acromegaly using medroxyprogesterone acetate]. Linquette M; Fossati P; Cappoen JP; Deconninck B; Derrien G Ann Endocrinol (Paris); 1973; 34(2):220-1. PubMed ID: 4745279 [No Abstract] [Full Text] [Related]
14. [The heart in acromegaly: an echocardiographic study]. Kawanishi H; Suda K; Mori T; Chiba T; Matsuda Y; Inatome T; Inoh T; Yokota Y; Matsumoto K; Fukuzaki H J Cardiogr; 1984 Oct; 14(3):459-69. PubMed ID: 6242154 [TBL] [Abstract][Full Text] [Related]
15. Cardiac function in acromegaly. A clinical and hemodynamic study. Just H; Nieschlag E; Nicolescu RF; Kröger FJ; Overzier C Acta Cardiol; 1974; 29(2):89-103. PubMed ID: 4274682 [No Abstract] [Full Text] [Related]
16. [Evolution of plasma somatotropin levels in acromegaly treated with medroxyprogesterone acetate]. Strauch G; Bricaire H Ann Endocrinol (Paris); 1973; 34(2):228-31. PubMed ID: 4745282 [No Abstract] [Full Text] [Related]
17. Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment. Warszawski L; Kasuki L; Sá R; Dos Santos Silva CM; Volschan I; Gottlieb I; Pedrosa RC; Gadelha MR Pituitary; 2016 Dec; 19(6):582-589. PubMed ID: 27591859 [TBL] [Abstract][Full Text] [Related]
18. [Terminal cardiac manifestations of acromegaly]. Lainée J; Slama R; Motte C; Aubert P Ann Med Interne (Paris); 1972 Apr; 123(4):425-9. PubMed ID: 4263230 [No Abstract] [Full Text] [Related]